Angelo Scopelianos Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Angelo Scopelianos.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Angelo Scopelianos. Angelo Scopelianos is Chief R&D Officer in Axogen, Inc. ($LECT) and VP Research & Development in AxoGen, Inc. ($LECT).
Latest Insider Trading Transactions of Angelo Scopelianos
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2021 | LECT | Axogen, Inc. | Scopelianos Angelo | Chief R&D Officer | Option Exercise | A | 0.00 | 16,500 | 0 | 16,500 | |
| Mar 18 2021 | LECT | Axogen, Inc. | Scopelianos Angelo | Chief R&D Officer | Option Exercise | A | 20.91 | 34,000 | 710,940 | 34,000 | |
| Mar 18 2021 | LECT | Axogen, Inc. | Scopelianos Angelo | Chief R&D Officer | Option Exercise | A | 0.00 | 16,500 | 0 | 16,500 | |
| Mar 18 2021 | LECT | Axogen, Inc. | Scopelianos Angelo | Chief R&D Officer | Option Exercise | A | 20.91 | 34,000 | 710,940 | 34,000 | |
| Feb 18 2021 | LECT | Axogen, Inc. | Scopelianos Angelo | Chief R&D Officer | Payment of Exercise | F | 18.71 | 406 | 7,596 | 7,046 | 7.5 K to 7 K (-5.45 %) |
| Feb 18 2021 | LECT | Axogen, Inc. | Scopelianos Angelo | Chief R&D Officer | Grant | A | 0.00 | 1,325 | 0 | 7,452 | 6.1 K to 7.5 K (+21.63 %) |
| Dec 30 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Sell | S | 17.81 | 567 | 10,098 | 5,529 | 6.1 K to 5.5 K (-9.30 %) |
| Dec 30 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Grant | A | 0.00 | 2,300 | 0 | 6,096 | 3.8 K to 6.1 K (+60.59 %) |
| Mar 18 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Option Exercise | A | 0.00 | 10,000 | 0 | 22,000 | |
| Mar 18 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
| Mar 18 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Option Exercise | A | 8.61 | 24,000 | 206,640 | 24,000 | |
| Feb 20 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Payment of Exercise | F | 14.68 | 394 | 5,784 | 2,249 | 2.6 K to 2.2 K (-14.91 %) |
| Feb 20 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Grant | A | 0.00 | 1,326 | 0 | 2,643 | 1.3 K to 2.6 K (+100.68 %) |
| Dec 31 2018 | LECT | AxoGen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Option Exercise | A | 0.00 | 4,600 | 0 | 4,600 | |
| Dec 31 2018 | LECT | AxoGen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Option Exercise | A | 19.17 | 32,900 | 630,693 | 32,900 | |
| Sep 05 2018 | LECT | AxoGen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Option Exercise | A | 45.00 | 40,000 | 1,800,000 | 40,000 |
Page: 1